Iranian-made COVIran up to 70% effective against coronavirus

The Iranian-made vaccine, COVIran, started the third human trial phase, after proving safe and effective against the virus in previous trials. The third phase will involve injecting the jabs to a statistical population of 20,000 volunteers. Developers say they are certain that the vaccine provides immunity of up to 70 percent against the coronavirus. But it's only after the third phase that an accurate figure can be achieved.

SS